New heart pump could offer lifeline for advanced heart failure patients

NCT ID NCT07700810

Not yet recruiting Disease control Sponsor: Shenzhen Core Medical Technology CO.,LTD. Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This trial tests a device called the Corheart 6, a left ventricular assist system that helps pump blood in people with advanced left ventricular heart failure. The study includes 100 adults aged 18 to 75 with severe heart failure symptoms despite optimal medical therapy. The main goal is to see if the device helps patients survive without a disabling stroke for six months, or if it allows them to receive a heart transplant or recover enough to have the device removed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a left ventricular assist device called Corheart 6
What this could lead to: If successful, this device could offer a new option for people with advanced heart failure to survive longer or bridge to a heart transplant.
What could go wrong: This is an early-stage trial with only 100 participants, so results may not apply to everyone. Risks include stroke, device problems, or the need for reoperation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates